OraSure Technologies Inc OSUR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if OSUR is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $5.25
- Day Range
- $5.22–5.34
- 52-Week Range
- $4.38–8.43
- Bid/Ask
- $5.32 / $5.33
- Market Cap
- $406.65 Mil
- Volume/Avg
- 108,886 / 952,081
Key Statistics
- Price/Earnings (Normalized)
- 5.00
- Price/Sales
- 0.96
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.47%
Company Profile
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Growth
- Total Number of Employees
- 638
- Website
- https://www.orasure.com
Comparables
Valuation
|
Metric
|
OSUR
|
301060
|
SRDX
|
|---|---|---|---|
Price/Earnings (Normalized) | 5.00 | 28.04 | 40.60 |
Price/Book Value | 0.90 | 1.88 | 3.08 |
Price/Sales | 0.96 | 1.54 | 2.68 |
Price/Cash Flow | 4.08 | 6.20 | 17.02 |
Price/Earnings
OSUR
301060
SRDX
Financial Strength
|
Metric
|
OSUR
|
301060
|
SRDX
|
|---|---|---|---|
Quick Ratio | 8.36 | 2.65 | 3.75 |
Current Ratio | 9.77 | 3.20 | 4.84 |
Interest Coverage | — | 3.73 | 3.75 |
Quick Ratio
OSUR
301060
SRDX
Profitability
|
Metric
|
OSUR
|
301060
|
SRDX
|
|---|---|---|---|
Return on Assets (Normalized) | 16.88% | 0.70% | 5.17% |
Return on Equity (Normalized) | 19.51% | 1.18% | 8.16% |
Return on Invested Capital (Normalized) | 18.86% | 1.24% | 8.20% |
Return on Assets
OSUR
301060
SRDX
Medical Instruments & Supplies Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ISRG
| Intuitive Surgical Inc | Qvxnsqptx | Mskwb | $132.1 Bil | |
BDX
| Becton Dickinson & Co | Cfkyrqf | Czvsy | $67.4 Bil | |
ALC
| Alcon Inc | Hptmywdk | Rhwwzsh | $39.1 Bil | |
CLPBY
| Coloplast A/S ADR | Gdzggkprm | Mxts | $28.8 Bil | |
WST
| West Pharmaceutical Services Inc | Rfvnmnzbd | Phrvl | $27.6 Bil | |
RMD
| ResMed Inc | Wsbvkrjxg | Gncblfh | $26.1 Bil | |
BAX
| Baxter International Inc | Wjzctsfrp | Kndvf | $20.1 Bil | |
COO
| The Cooper Companies Inc | Zjpscbxzn | Wjkrydp | $18.0 Bil | |
HOLX
| Hologic Inc | Tbfrlzs | Zzhfyz | $17.6 Bil | |
TFX
| Teleflex Inc | Fsnt | Vpfr | $9.8 Bil |